Related Experiment Video
Updated: Apr 3, 2026

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
Published on: August 22, 2025
[Management of cannabinoid hyperemesis syndrome]
Jonas Ballaman1, Caroline Reiff1, Ulysse Voirol2
1Centre santé Blécherette, Unisanté, Rue Elisabeth Jeanne de Cerjat 18, 1018 Lausanne.
None:
Cannabinoid hyperemesis syndrome (CHS) is a condition that affects approximately one-third of cannabis users. Symptoms include recurrent episodes of vomiting, nausea, and abdominal pain. Affected individuals often find temporary relief by taking hot baths or showers. This article provides an overview of the typical manifestations of CHS and an update on the current knowledge surrounding its cause and treatment, illustrated by a clinical case.
More Related Videos
05:33Author Spotlight: Alleviating Nausea and Vomiting in Pregnancy with Safe and Effective Auricular Acupuncture
Published on: August 4, 2023
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chronic Pancreatitis II: Collaborative Care
Assessment:
Pharmaceutical Poisoning: Treatment Strategies